JNJ acquires ABMD for $380/sh cash—a 51% premium to yesterday’s close: https://finance.yahoo.com/news/johnson-johnson-acquire-abiomed-103000301.html The deal includes a CVR worth as much as $35/sh. The nominal deal value (excluding the CVR) is $16.6B.